Joining forces: Leveraging novel combination therapies to combat infections with eukaryotic pathogens.

Authors :: Ham RE
Temesvari LA
Source :: PLoS pathogens [PLoS Pathog] 2020 Dec 31; Vol. 16 (12), pp. e1009081. Date of Electronic Publication: 2020 Dec 31 (Print Publication: 2020).
Publication Year :: 2020
Abstract: Competing Interests: The authors have declared that no competing interests exist.

Subjects :: Anti-Infective Agents pharmacology
Antifungal Agents pharmacology
Antineoplastic Agents pharmacology
Antineoplastic Combined Chemotherapy Protocols pharmacology
Drug Resistance drug effects
Drug Resistance, Microbial drug effects
Drug Resistance, Microbial physiology
Drug Therapy, Combination trends
Eukaryota pathogenicity
Humans
Drug Resistance physiology
Drug Therapy, Combination methods

Full Text Access

Tools